Profile Image

Staff Profile

Edit

Career Summary

Biography

Paul has a keen interest in understanding the cellular and molecular mechanisms of diseases, so that better diagnoses and treatment strategies can be developed. He completed a BSc (Hon) Class 1 (1985-1989) and a PhD (awarded 1995) from the University of Newcastle, Australia. He then travelled to the USA (1995-1998) and completed post-doctoral research at the University of Wisconsin. His research background during his PhD and postdoctoral work was in cancer biology where he gained experience in cellular and molecular biology techniques. In March 1998, Paul returned to Australia and took the opportunity to focus on the neurobiology of schizophrenia and joined the Schizophrenia Research Institute (formerly the Neuroscience Institute of Schizophrenia and Allied Disorders) as a Research Officer (1998-2000) and Senior Research Officer (2000-2004). In 2004, Paul was appointed to an academic position in the School of Biomedical Sciences and Pharmacy, Faculty of Health University of Newcastle.

Paul’s research from 1998 to date has focused on the neurobiology and genetics underpinning schizophrenia. He has conducted and collaborated on world-class studies detailing the changes to gene expression in the brain and also the blood from patients with schizophrenia. These studies showed that people with schizophrenia have distinct changes in their expression of genes in their brains and the blood. Interestingly many of these studies suggest changes in genes that have roles in the immune system and inflammatory processes/ As part of these efforts Paul played a major role in the establishment of the Australian Schizophrenia Research Bank (ASRB), which recruits participants with schizophrenia and controls and collects clinical and cognitive data as well as blood samples for genetic analysis and MRI structural brain scans from the participants. This huge data resource is currently being investigated by many groups to improve our understanding of what causes schizophrenia so that we can better identify who is likely to develop schizophrenia so that we can identify new treatments or preventative strategies for this devastating disorder.

More recently Paul established two new projects. One project is investigating why people with schizophrenia have more inhibitory interneurons in the white matter underneath the cortex of brain regions known to be affected in schizophrenia. The other project is investigating the levels of autoantibodies directed against neuronal antigens in people with schizophrenia.

Qualifications

  • PhD, University of Newcastle, 27/04/1995
  • Bachelor of Science, University of Newcastle, 13/05/1989
  • Bachelor of Science (Honours), University of Newcastle, 11/05/1990
  • Graduate Certificate Practice of Tertiary Teaching, University of Newcastle, 10/12/2007

Research

Research keywords

  • Gene expression
  • Interneurons
  • Neurobiology
  • Schizophrenia

Research expertise

Paul's research expertise is in cell and molecular biology. His research efforts during his PhD and postdoctoral training were directed at cancer biology using standard cell culture assays, immunofluorescnece labling of cultured cells, flow cytometry and molecular biology techniques. Since 1998, Paul has focused on the neurobiology of schizophrenia and has developed additional experience with molecular techniques to study gene expression changes in brain and blood samples. He also has experience in using immunolablelling techniques (immunofluorescence and immunohistochemistry) coupled with microscopy and cell counting to study changes in neurons in the brains of people with schizophrenia and in rodent models.

Fields of Research

CodeDescriptionPercentage
110900Neurosciences45
110319Psychiatry (Incl. Psychotherapy)45
060410Neurogenetics10

Memberships

Body relevant to professional practice.

  • General Member - Australian Neuroscience Society

Other

  • Affiliated Scientist - Schizophrenia Research Institute

Awards

Research Award.

1991Australian Postgraduate Research Award
University of Newcastle (Australia)

Invitations

Tachykinin NK1 receptor immunoreactivity is increased in the prefrontal cortex in schizophrenia
International Congress On Schizophrenia Research, Canada (Invited to give oral preseantation)
2001

Collaboration

My current research interests are in the understanding of the neurobiology and genetics of schizophrenia so that better diagnoses and treatment strategies can be developed.

Currently my research collaborations are around the following projects:

1. Investigation of the genetic basis of schizophrenia with the Neurobehavioural Genetics Unit

2. Investigation of the neurobiology and changes to interneurons in the white matter of the brain in schizophrenia.

3. Investigation of the level of autoantibodies directed against neuronal antigens in people with schizophrenia.

4. The Australian Schizophrenia Research Bank: http://www.schizophreniaresearch.org.au/bank/

Administrative

Administrative expertise

Paul was the B. Biomedical Science Program Convenor from 2008 to 2012

Teaching

Teaching keywords

  • Biomedical Science
  • Cell Biology
  • Pharmacology
  • Research Skills

Teaching expertise

Paul has expertise in teaching basic cell and molecular biology, pharmacology and coordinates a course on professional skills for biomedical science students. He has taught into the Biomedical Science, Medicine, Pharmacy, Nursing and Physiotherapy Programs.

Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2006Bowden NA, Weidenhofer JC, Scott R, Schall U, Todd J, Michie PT, Tooney PA, 'Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia', Schizophrenia Research, 82 175-183 (2006) [C1]
2001Tooney PA, Crawter VC, Chahl LA, 'Increased Tachykinin NK1 Receptor Immunoreactivity in the Prefrontal Cortex in Schizophrenia', Biological Psychiatry, 49 523-527 (2001) [C1]

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Journal article (43 outputs)

YearCitationAltmetricsLink
2014Kumarasinghe N, Rasser PE, Mendis J, Bergmann J, Knechtel L, Oxley S, et al., 'Age effects on cerebral grey matter and their associations with psychopathology, cognition and treatment response in previously untreated schizophrenia patients', Neurology Psychiatry and Brain Research, 20 29-36 (2014) [C1]
2014McCarthy-Jones S, Green MJ, Scott RJ, Tooney PA, Cairns MJ, Wu JQ, et al., 'Preliminary evidence of an interaction between the FOXP2 gene and childhood emotional abuse predicting likelihood of auditory verbal hallucinations in schizophrenia', JOURNAL OF PSYCHIATRIC RESEARCH, 50 66-72 (2014) [C1]
2014Oldmeadow C, Mossman D, Evans TJ, Holliday EG, Tooney PA, Cairns MJ, et al., 'Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci.', J Psychiatr Res, 52 44-49 (2014) [C1]
2014Gardiner E, Carroll A, Tooney PA, Cairns MJ, 'Antipsychotic drug-associated gene-miRNA interaction in T-lymphocytes', International Journal of Neuropsychopharmacology, 17 929-943 (2014)
2014Green MJ, Chia T-Y, Cairns MJ, Wu J, Tooney PA, Scott RJ, Carr VJ, 'Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia', JOURNAL OF PSYCHIATRIC RESEARCH, 49 43-50 (2014)
2013Kumarasinghe N, Beveridge NJ, Gardiner E, Scott RJ, Yasawardene S, Perera A, et al., 'Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication', INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 16 1483-1503 (2013) [C1]
2013Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, et al., 'Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia', MOLECULAR PSYCHIATRY, 18 774-780 (2013) [C1]
2013Santarelli DM, Liu B, Duncan CE, Beveridge NJ, Tooney PA, Schofield PR, Cairns MJ, 'Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine', PSYCHOPHARMACOLOGY, 227 67-78 (2013) [C1]
2013Carroll AP, Tooney PA, Cairns MJ, 'Context-specific microRNA function in developmental complexity', Journal of Molecular Cell Biology, 5 73-84 (2013) [C1]
2013Cairns MJ, Carroll AP, Tooney PA, 'Design and interpretation of microRNA-reporter gene activity', Analytical Biochemistry, 437 164-171 (2013) [C1]
2013Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA, et al., 'Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia', Molecular Psychiatry, (2013) [C1]
2013Gardiner EJ, Cairns MJ, Liu B, Beveridge NJ, Carr V, Kelly B, et al., 'Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells', JOURNAL OF PSYCHIATRIC RESEARCH, 47 425-437 (2013) [C1]
2012Kumarasinghe KMN, Tooney PA, Schall UA, 'Finding the needle in the haystack: A review of microarray gene expression research into schizophrenia', Australian and New Zealand Journal of Psychiatry, 46 598-610 (2012) [C1]

Co-authors: Ulrich Schall

2012Carroll AP, Tran N, Tooney PA, Cairns MJ, 'Alternative mRNA fates identified in microRNA-associated transcriptome analysis', BMC Genomics, 13 1-19 (2012) [C1]
2012Gardiner EJ, Beveridge NJ, Wu JQ, Carr VJ, Scott R, Tooney PA, Cairns MJ, 'Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells', Molecular Psychiatry, 17 827-840 (2012) [C1]

Co-authors: Rodney Scott

2012Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott R, Carr VJ, Cairns MJ, 'Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia', PLoS One, 7 e36351 (2012) [C1]

Co-authors: Rodney Scott

2011Santarelli DMF, Beveridge NJ, Tooney PA, Cairns MJ, 'Upregulation of dicer and MicroRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia', Biological Psychiatry, 69 180-187 (2011) [C1]
2011Case VS, Soyland A, Tooney PA, Thompson PM, Rasser PE, Schall UA, et al., 'Gray matter deficits, mismatch negativity, and outcomes in schizophrenia', Schizophrenia Bulletin, 37 131-140 (2011) [C1]
2010Loughland CM, Draganic D, McCabe KL, Richards JM, Nasir MA, Allen J, et al., 'Australian Schizophrenia Research Bank: A database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia', Australian and New Zealand Journal of Psychiatry, 44 1029-1035 (2010) [C1]
2010Beveridge NJ, Gardiner EJ, Carroll AP, Tooney PA, Cairns MJ, 'Schizophrenia is associated with an increase in cortical microRNA biogenesis', Molecular Psychiatry, 15 1176-1189 (2010) [C1]
2009Weidenhofer JC, Scott R, Tooney PA, 'Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: Effects of antipsychotic drugs', Journal of Psychiatric Research, 43 282-290 (2009) [C1]
2009Anderson WB, Graham BA, Beveridge NJ, Tooney PA, Brichta AM, Callister RJ, 'Different forms of glycine- and GABA(A)-receptor mediated inhibitory synaptic transmission in mouse superficial and deep dorsal horn neurons', Molecular Pain, 5 1-16 (2009) [C1]
2009Beveridge NJ, Tooney PA, Carroll AP, Tran N, Cairns MJ, 'Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation', Cellular Signalling, 21 1837-1845 (2009) [C1]
2008Beveridge NJ, Tooney PA, Carroll AP, Gardiner EJ, Bowden NA, Scott R, et al., 'Dysregulation of miRNA 181b in the temporal cortex in schizophrenia', Human Molecular Genetics, 17 1156-1168 (2008) [C1]
2008Bowden NA, Scott R, Tooney PA, 'Altered gene expression in the superior temporal gyrus in schizophrenia', BMC Genomics, 9 1-12 (2008) [C1]
2007Bowden NA, Scott R, Tooney PA, 'Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia', Schizophrenia Research, 89 165-168 (2007) [C1]
2006Weidenhofer JC, Yip JR, Zavitsanou K, Huang XF, Chahl LA, Tooney PA, 'Immunohistochemical localisation of the NK1 receptor in the human amygdala: Preliminary investigation in schizophrenia', Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30 1313-1321 (2006) [C1]
2006Bowden NA, Weidenhofer JC, Scott R, Schall U, Todd J, Michie PT, Tooney PA, 'Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia', Schizophrenia Research, 82 175-183 (2006) [C1]
2006Bowden NA, Tooney PA, Scott R, 'Gene expression profiling of xeroderma pigmentosum', Hereditary Cancer in Clinical Practice, 4 103-110 (2006) [C1]
2006Weidenhofer J, Bowden NA, Scott RJ, Tooney PA, 'Dysfunction of genes regulating membrane exocytosis in schizophrenia', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 40 A129-A129 (2006)
2005Weidenhofer JC, Bowden NA, Scott R, Tooney PA, 'Altered gene expression in the amygdala in schizophrenia: up-regulation of genes located in the cytomatrix active zone', Molecular and Cellular Neuroscience, 31 243-250 (2005) [C1]
2005Tooney PA, Anderson WB, Lynch-Frame AM, Chahl LA, 'The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in guinea-pig brain (Short Communication)', Neuroscience Letters, 383 155-159 (2005) [C1]
2004Tooney PA, Chahl LA, 'Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia', Progress in Neuro-Psychopharmacology & Biological Psychiatry, 28 273-278 (2004) [C1]
2002Tooney PA, Yip J, Zavitsanou K, Huang X-F, Chahl LA, 'Distribution of Tachykinin Receptors in the Human Amygdala', Proceedings of the Australian Neuroscience Society, 13 182 (2002) [C3]
2001Tooney PA, Crawter VC, Chahl LA, 'Increased Tachykinin NK1 Receptor Immunoreactivity in the Prefrontal Cortex in Schizophrenia', Biological Psychiatry, 49 523-527 (2001) [C1]
2001Tooney PA, Crawter VC, Chahl LA, 'Tachykinin NK1 receptor immunoreactivity is increased in the prefrontal cortex in schizophrenia', SCHIZOPHRENIA RESEARCH, 49 64-64 (2001)
2000Tooney PA, Au GG, Chahl LA, 'Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex', Neuroscience Letters, 283 185-188 (2000) [C1]

Co-authors: Gough Au

1998Tooney PA, Sakai T, Sakai K, Aeschlimann D, Mosher DF, 'Restricted localization of thrombospondin-2 protein during mouse embryogenesis: A comparison to thrombospondin-1', MATRIX BIOLOGY, 17 (2) 131-143 (1998) [C1]
1993Tooney P, Agrez MV, Burns GF, 'A re-examination of the molecular mechanism of cell movement', Immunology and Cell Biology, 71 131-139 (1993) [C1]
1993AGREZ MV, TOONEY P, BURNS GF, 'SRC-RELATED PROTEIN TYROSINE KINASES ARE INVOLVED IN INTEGRIN-MEDIATED COLLAGEN REORGANIZATION BY FIBROBLASTS', JOURNAL OF CELLULAR BIOCHEMISTRY, 113-113 (1993)
1993BURNS GF, TOONEY PA, MELDRUM CJ, 'GLYCOPROTEIN-88 (CD36) BINDS TUBULIN AND ENDOGENOUS THROMBOSPONDIN', JOURNAL OF CELLULAR BIOCHEMISTRY, 158-158 (1993)
1993BURNS GF, TOONEY P, DENICHILO M, MELDRUM C, DORAHY D, 'THE BIOLOGY OF CD36 - AN INTEGRIN-ASSOCIATED ADHESION MOLECULE', JOURNAL OF LEUKOCYTE BIOLOGY, 109-109 (1993)
1990Smart YC, Tooney PA, Farrelly ML, Brien JH, Burton RC, 'Natural cytotoxic cells and tumour surveillance', European Journal of Cancer, 26 863-864 (1990) [C1]
Show 40 more

Conference (43 outputs)

YearCitationAltmetricsLink
2012Henskens FA, Paul DJ, Loughland CM, Bridge JE, McCabe KL, Catts S, et al., 'The Australian Schizophrenia Research Biobank (ASRB): IT development and management of a live e-research system', Schizophrenia Research, Florence, Italy (2012) [E3]
2012Carroll AP, Tooney PA, Cairns MJ, 'Biological investigation of schizophrenia-associated miRNA dysregulation', Abstract Book. Biological Psychiatry Australia Scientific Meeting, Parkville, Vic (2012) [E3]
2012Loughland CM, McCabe KL, Bridge JE, Henskens FA, Catts S, Jablensky A, et al., 'The Australian Schizophrenia Research Biobank (ASRB): An audit of the first five years of recruitment resource access', Schizophrenia Research, Florence, Italy (2012) [E3]
2012Gardiner EJ, Cairns MJ, Beveridge NJ, Liu B, Mossman D, Carr VJ, et al., 'Differential gene expression in peripheral blood mononuclear cells from a large cohort of participants with schizophrenia', Abstracts. Australian Neuroscience Society 32nd Annual Meeting, Gold Coast, Queensland (2012) [E3]

Co-authors: Rodney Scott

2011Wu J, Tooney PA, Wang X, Cairns MJ, 'Quantitative transcriptome sequencing reveals altered presynaptic vesicle trafficking and myelination in the temporal cortex in schizophrenia', Presentation Abstracts: XIXth World Congress of Psychiatric Genetics, Washington, DC (2011) [E3]
2011Mossman D, Tooney PA, Cairns MJ, Kelly BJ, Carr V, Scott R, 'Identification of alternatively spliced gene variants in schizophrenia', Schizophrenia Bulletin, Colorado Springs, CO (2011) [E3]
2011Beveridge NJ, Santarelli DMF, Tooney PA, Webster MJ, Weickert CS, Cairns MJ, 'Maturation of the human dorsolateral prefrontal cortex coincides with a dynamic shift in microRNA expression', The Proceedings of the First Scientific Meeting of Biological Psychiatry Australia, Melbourne, VIC (2011) [E3]
2011Cairns MJ, Wu JQ, Tooney PA, Wang X, 'RNA-seq reveals significant alteration of cortical promoter usage and splicing in schizophrenia', The Proceedings of the First Scientific Meeting of Biological Psychiatry Australia, Melbourne, VIC (2011) [E3]
2011Loughland CM, McCabe KL, Catts S, Jablensky A, Henskens FA, Michie PT, et al., 'The Australian Schizophrenia Research Bank (ASRB): The first 550 schizophrenia sample profile', Schizophrenia Bulletin, Schizophrenia Bulletin (2011) [E3]
2011Gardiner EJ, Beveridge NJ, Liu B, Carr VJ, Scott R, Tooney PA, Cairns MJ, 'Gene expression profiling in peripheral blood mononuclear cells in schizophrenia', The Proceedings of the First Scientific Meeting of Biological Psychiatry Australia, Melbourne, VIC (2011) [E3]

Co-authors: Rodney Scott

2010Carr V, Loughland C, McCabe K, Nasir A, Catts S, Jablensky A, et al., 'THE AUSTRALIAN SCHIZOPHRENIA RESEARCH BANK (ASRB): DEMOGRAPHIC, CLINICAL AND NEUROPSYCHOLOGICAL PROFILE OF PARTICIPANTS WITH SCHIZOPHRENIA', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010) [E3]
2010Santarelli DMF, Beveridge NJ, Tooney PA, Cairns MJ, 'Upregulation of dicer and microrna expression in the dorsolateral prefrontal cortex (Brodmann's Area 46) in schizophrenia', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]
2010Wu JQ, Cairns MJ, Scott R, Carr V, Mowry B, Jablensky A, et al., 'Genome wide analysis of DNA copy number in schizophrenia reveals loss of heterozygosity on chromosome 6P22.1 and 16P11.2-11.1', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]
2010Kumarasinghe N, Schall UA, Beveridge NJ, Gardiner EJ, Tooney PA, 'Gene expression analysis of treatment- naive schizophrenia patients', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]

Co-authors: Ulrich Schall

2010Gardiner E, Beveridge NJ, Santarelli D, Wu J, Carr V, Scott RJ, et al., 'MIRNA EXPRESSION PROFILING IN PATIENTS WITH SCHIZOPHRENIA', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010) [E3]
2010Beveridge NJ, Tooney PA, Webster M, Weickert CS, Cairns MJ, 'Microrna expression throughout postnatal development if the human dorsolateral prefrontal cortex', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]
2010Paulik G, Atkinson RJ, Carr V, Clark S, Curtis J, Langdon R, et al., 'Minds in transition (MINT): A prospective study examining neurocognitive correlates of transition from ultra-high risk mental state to schizophrenia', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]
2010Gardiner EJ, Beveridge NJ, Santarelli DMF, Wu JQ, Carr V, Scott R, et al., 'Mirna expression profiling in patients with schizophrenia', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]

Co-authors: Rodney Scott

2009Beveridge NJ, Carroll AP, Tooney PA, Cairns MJ, 'MicroRNA changes in the prefrontal and temporal cortices in schizophrenia', Schizophrenia Bulletin, San Diego, CA (2009) [E3]
2009Cairns MJ, Beveridge NJ, Carroll AP, Tooney PA, Gardiner EJ, Santarelli DMF, 'Alteration of microRNA biogenesis in schizophrenia and its implications for synaptic structure and function', Schizophrenia Bulletin, San Diego, CA (2009) [E3]
2009Cairns MJ, Beveridge NJ, Carroll AP, Gardiner EJ, Tooney PA, Santarelli DMF, 'Alteration of cortical microRNA biogenesis in schizophrenia and its influence on gene expression', XVIIth World Congress on Psychiatric Genetics: Abstract Book, San Diego, CA (2009) [E3]
2008Henry C, Watkins A, O'Donnell M, Newall HD, Ward PB, Curtis J, Tooney PA, 'Gene polymorphisms, weight gain and metabolic syndrome in first episode psychosis', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2008Beveridge NJ, Carroll AP, Tooney PA, Cairns MJ, 'Dysregulation of miRNA 181b in the temporal cortex in schizophrenia', 2008 Lorne Genome Conference Delegate Handbook, Lorne, VIC (2008) [E3]
2008Schall UA, Rasser PE, Todd J, Michie PT, Ward PB, Johnston P, et al., 'A simple auditory event-related potential is linked to cerebral grey matter pathology in schizophrenia', Schizophrenia Research, Venice, Italy (2008) [E3]
2008Carroll AP, Beveridge NJ, Tooney PA, Cairns MJ, 'Identification of biologically relevant miRNA targets through the bidirectional modulation of miRNA expression', 2008 Lorne Genome Conference Delegate Handbook, Lorne, VIC (2008) [E3]
2008Carroll AP, Beveridge NJ, Gardiner EJ, Tooney PA, Cairns MJ, 'Identification of biologically relevant, schizophrenia-associated MicroRNA targets', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2008Rasser PE, Todd J, Thompson PM, Michie PT, Ward PB, Johnston P, et al., 'Linking cerebral grey matter and mismatch negativity (MMN) in schizophrenia', NeuroImage, Melbourne, VIC (2008) [E3]
2008Beveridge NJ, Carroll AP, Gardiner EJ, Tooney PA, Cairns MJ, 'MicroRNA changes in the prefrontal and temporal cortices in schizophrenia', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2008Beveridge NJ, Tooney PA, Carroll AP, Cairns MJ, 'MicroRNA changes in the cerebral cortex in schizophrenia', Proceedings of the Australian Society for Biochemistry and Molecular Biology, Canberra, ACT (2008) [E3]
2008Gardiner EJ, Carroll AP, Beveridge NJ, Tooney PA, Cairns MJ, 'Investigation of miRNA influence on RGS4 and NRG1 gene expression in schizophrenia', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2008Newall HD, Ward PB, Curtis J, Tooney PA, Henry C, Watkins A, O'Donnell M, '5HT2C gene polymorphisms, weight gain and metabolic syndrome in first episode psychosis', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2007Cairns MJ, Beveridge NJ, Carroll A, Scott R, Tooney PA, 'Investigation of post transcriptional gene silencing in schizophrenia', Schizophrenia Bulletin (Abstracts of the 11th International Congress on Schizophrenia Research), Colorado Springs, Colorado (2007) [E3]

Co-authors: Rodney Scott

2007Tooney PA, Scott R, Cairns MJ, Bowden NA, 'Altered gene expression in the superior temporial gyrus in schizophrenia', Schizophrenia Bulletin (Abstracts of the 11th International Congress on Schizophrenia Research), Colorado Springs, Colorado (2007) [E3]
2006Weidenhofer JC, Bowden NA, Scott R, Tooney PA, 'Dysfunction of genes regulating membrane exocytosis in schizophrenia (Poster presentation)', Australian and New Zealand Journal of Psychiatry (Vol 40, noS2), Fremantle, Western Australia (2006) [E3]
2005Bowden NA, Weidenhofer JC, Scott R, Schall UA, Todd J, Michie PT, Tooney PA, 'Classification of schizophrenia using differential gene expression in peripheral blood lymphocytes', Human Genetics Society of Australasia, Newcastle (2005) [E3]
2005Russell SH, Loughland CM, Tooney PA, Scott R, Carr VJ, 'The Hunter DNA bank for schizophrenia and allied disorders: A unique Australian Resource facilitating genetic research into mental illness', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
2005Anderson WB, Tooney PA, Ross FB, 'Complexation of Cannabinoidergic and Serotonergic G Protein-Coupled Receptors', Proceedings of the 25th Annual 'Silver Jubilee' Meeting, Perth Convention Centre (2005) [E3]
2004Bowden NA, Weidenhofer JC, Scott R, Todd J, Case V, Schall UA, Tooney PA, 'Distinct Gene Expression Profiles due to Age in Schizophrenia', Proceedings of the Australian Neuroscience Society, Melbourne (2004) [E3]
2004Bowden NA, Weidenhofer JC, Scott R, Todd J, Case V, Schall UA, Tooney PA, 'Differental Gene Expression in Peripheral Blood Lymphocytes in Schizophrenia', Proceedings of the Australian Neuroscience Society, Melbourne (2004) [E3]
2004Bowden NA, Weidenhofer JC, Scott R, Todd J, Case V, Schall UA, Tooney PA, 'Altered Expression of Brain Related Genes in Lymphocytes in Schizophrenia', American Journal of Medical Genetics, Ireland (2004) [E3]
2004Weidenhofer JC, Bowden NA, Scott R, Tooney PA, 'Altered Gene Expression Profiles in the Amygdala in Schizophrenia', Proceedings of the Australian Neuroscience Society, Melbourne (2004) [E3]
2004Weidenhofer JC, Bowden NA, Scott R, Tooney PA, 'Gene Profiling in the Amygdala in Schizophrenia', American Journal of Medical Genetics, Ireland (2004) [E3]
2000Tooney PA, Au GG, Chahl LA, 'Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain', Proceedings of the Australian Physiological and Pharmacological Society Symposium Tachykinins: The Challenge Continues, Newcastle, Australia (2000) [E1]

Co-authors: Gough Au

Show 40 more
Edit

Grants and Funding

Summary

Number of grants49
Total funding$6,390,496

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2014 (2 grants)

Genetic and Environmental Determinants of Depressive Symptoms: Trajectory and Outcomes in a Longitudinal Population Data Set$30,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Brian Kelly, Associate Professor Paul Tooney, Professor Rodney Scott, Professor John Attia, Conjoint Associate Professor Murray Cairns, Professor Vaughan Carr
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$30,00020142014
GNo:G1400594

Neurobiological Investigation of Interstitial White Matter Neurons in a Maternal Infection Activation Model of Schizophrenia$2,608
Funding Body: Australian Rotary Health

Project Team
Associate Professor Paul Tooney, Doctor Phil Jobling, Doctor Brett Graham
SchemeRole
Ian Scott ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$2,60820142016
GNo:G1301103

2013 (2 grants)

Leica TP 1020 Automatic Tissue Processor for histology applications$35,000
Funding Body: NHMRC (National Health & Medical Research Council)

Ultra-Low Temperature Cryogenic Freezer$24,596
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Doctor Jude Weidenhofer, Doctor Rick Thorne, Doctor Kathryn Skelding, Doctor Nikki Verrills, Doctor Pradeep Tanwar, Associate Professor Phillip Dickson, Conjoint Associate Professor Murray Cairns, Professor Hubert Hondermarck, Professor Xu Dong Zhang, Associate Professor Estelle Sontag, Doctor Chen Chen Jiang, Associate Professor Liz Milward, Doctor Jean-Marie Sontag, Associate Professor Paul Tooney, Doctor Severine Roselli, Doctor Matt Dun, Doctor Chris Dayas, Doctor Lin Kooi Ong, Professor Dirk Van Helden, Mr Ben Copeland, Doctor Gabrielle Briggs, Emeritus Professor Leonie Ashman, Emeritus Professor John Rostas
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$24,59620132013
GNo:G1201189

2012 (2 grants)

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$30,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Mr Paul Rasser, Mr TIM Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$30,00020122012
GNo:G1200854

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$10,000
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Associate Professor Ute Vollmer-Conna, Mr Paul Rasser, Mr TIM Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020122012
GNo:G1201020

2011 (2 grants)

Emerging Research Leaders Program 2011$15,000
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Emerging Research Leaders ProgramChief Investigator
Total AmountFunding StartFunding Finish
$15,00020112011
GNo:G1101112

IMPLEN NanoPhotometer pearl$10,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Associate Professor Murray Cairns, Associate Professor Paul Tooney, Associate Professor Alan Brichta, Emeritus Professor John Rostas, Emeritus Professor Patricia Michie, Conjoint Professor Keith Jones, Professor Ulli Schall, Associate Professor Phillip Dickson, Doctor Frederick Walker, Doctor Rick Thorne, Doctor Chris Dayas, Doctor Nikki Verrills, Doctor Janet Holt, Doctor Severine Roselli, Doctor Kathryn Skelding, Doctor Jude Weidenhofer, Associate Professor Liz Milward, Doctor Charles De Bock, Doctor Julie Merriman-Jones, Doctor Jing Qin Wu, Doctor Bing Liu, Mr Dan Johnstone, Ms Belinda Goldie, Ms Natalie Beveridge
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020112011
GNo:G1100030

2010 (7 grants)

Molecular and cellular characterisation of schizophrenia associated dysfunction in microRNA biogenesis$478,500
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Associate Professor Murray Cairns, Professor Rodney Scott, Associate Professor Paul Tooney, Emeritus Professor John Rostas, Associate Professor Alan Brichta
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$478,50020102012
GNo:G0190196

Laser microdissection microscopy system for cell and development biology$350,000
Funding Body: ARC (Australian Research Council)

Laser microdissection microscopy system for cell and development biology$215,000
Funding Body: University of Newcastle

Targeting neuroinflammation to improve the efficacy of antidepressant drugs$50,000
Funding Body: BellBerry Limited

Project Team
Doctor Frederick Walker, Dr Kathryn Buller, Associate Professor Paul Tooney
SchemeRole
Near MissInvestigator
Total AmountFunding StartFunding Finish
$50,00020102012
GNo:G0900219

ABI 7500 Real Time PCR System $34,000
Funding Body: NHMRC (National Health & Medical Research Council)

Analysis of schizophrenia-associated gene and mircoRNA signatures in purified CD4 and CD8 positive T-cells$25,000
Funding Body: Hunter Children`s Research Foundation

Project Team
Conjoint Associate Professor Murray Cairns, Doctor Jing Qin Wu, Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$25,00020102010
GNo:G0900188

Do chiropractic spinal adjustments modulate brain derived neurotrophic factor levels in the brain - a study in the rodent$21,715
Funding Body: Australian Spinal Research Foundation

Project Team
Associate Professor Philip Bolton, Associate Professor Paul Tooney
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$21,71520102010
GNo:G0190387

2009 (4 grants)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$495,000
Funding Body: ARC (Australian Research Council)

An Advanced Mass Spectrometry Facility for Applications in Proteomics and Organic Chemistry$50,000
Funding Body: ARC (Australian Research Council)

Investigation of schizophrenia associated gene and miRNA expression in the dorsolateral prefrontal cortex$19,719
Funding Body: Schizophrenia Research Institute

Project Team
Conjoint Associate Professor Murray Cairns, Associate Professor Paul Tooney
SchemeRole
Postgraduate Research ScholarshipInvestigator
Total AmountFunding StartFunding Finish
$19,71920092011
GNo:G0190436

Leica VT1200S - Fully automated vibrating blade microtome$16,209
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Professor Robert Callister, Associate Professor Alan Brichta, Conjoint Professor Keith Jones, Associate Professor Jon Hirst, Doctor Brett Graham, Associate Professor Philip Bolton, Doctor Phil Jobling, Associate Professor Paul Tooney, Doctor Angela McPherson, Doctor Rebecca Lim, Doctor Ramatis De Oliveira, Mr Matthew Walsh
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$16,20920092009
GNo:G0189842

2008 (5 grants)

Neuro-behavioural genetics network research program$2,400,000
Funding Body: NSW Ministry of Health

Project Team
Conjoint Professor Vaughan Carr, Professor Rodney Scott, Associate Professor Paul Tooney, Professor Brian Kelly, Conjoint Associate Professor Murray Cairns
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$2,400,00020082010
GNo:G0189170

Micro-array gene expression and grey matter changes in treatment - naive schizophrenia patients in Sri Lanka$56,000
Funding Body: Schizophrenia Research Institute

Project Team
Professor Ulli Schall, Associate Professor Paul Tooney
SchemeRole
Postgraduate Research ScholarshipInvestigator
Total AmountFunding StartFunding Finish
$56,00020082009
GNo:G0189009

A road map of schizophrenia associated with gene and miRNA expression in the dorsolateral prefrontal cortex$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Conjoint Associate Professor Murray Cairns, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$25,00020082008
GNo:G0188461

Brain Science and Young People's Mental Health: A gene expression study in young people at ultra high risk of developing schizophrenia$25,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Emeritus Professor Patricia Michie, Professor Ulli Schall, Professor Rodney Scott, Associate Professor Helen Stain, Doctor Rebbekah Atkinson
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$25,00020082008
GNo:G0188475

Investigation of miRNA influence on NRG1 dysregulation in schizophrenia$16,000
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Conjoint Associate Professor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$16,00020082011
GNo:G0188594

2007 (5 grants)

HMRI Postdoctoral Fellowship in Youth Mental Health Research$150,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Ulli Schall, Emeritus Professor Patricia Michie, Associate Professor Paul Tooney, Associate Professor Helen Stain, Doctor Carmel Loughland, Conjoint Professor Vaughan Carr
SchemeRole
Postdoctoral FellowshipInvestigator
Total AmountFunding StartFunding Finish
$150,00020072009
GNo:G0188274

Gene silencing in the pathogenesis of schizophrenia$23,750
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Conjoint Associate Professor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$23,75020072010
GNo:G0187724

The functional characterization of schizophrenia-associated non-coding RNA expression$23,750
Funding Body: Schizophrenia Research Institute

Project Team
Associate Professor Paul Tooney, Conjoint Associate Professor Murray Cairns
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$23,75020072010
GNo:G0187725

Investigation of Genetic and epigenetic mechanism underlying dysregulation of RGS4 in schizophrenia$8,702
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney, Conjoint Associate Professor Murray Cairns
SchemeRole
Pilot GrantChief Investigator
Total AmountFunding StartFunding Finish
$8,70220072007
GNo:G0187862

International Congress on Schizphrenia Research, The Broadmoor, Colorado Sprins, Colorado, 28/3/2007 - 01/04/2007$2,500
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,50020072007
GNo:G0187387

2006 (2 grants)

PRC - Priority Research Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine (CIBM)$621,143
Funding Body: University of Newcastle

Project Team
Professor Pablo Moscato, Professor Rodney Scott, Emeritus Professor John Rostas, Professor John Forbes, Conjoint Professor Peter Hersey, Conjoint Professor Stephen Ackland, Conjoint Professor Wayne Smith, Emeritus Professor Peter Dunkley, Emeritus Professor Leonie Ashman, Professor John Attia, Associate Professor Phillip Dickson, Associate Professor Liz Milward, Professor Alistair Sim, Associate Professor Paul Tooney, Associate Professor Regina Berretta, Conjoint Professor David Sibbritt, Conjoint Professor Chris Levi, Professor Xu Dong Zhang, Conjoint Associate Professor Patricia Crock, Conjoint Associate Professor Jeannette Lechner-Scott
SchemeRole
Priority Research CentreInvestigator
Total AmountFunding StartFunding Finish
$621,14320062013
GNo:G0186919

Investigation of miRNAs in schizophrenia$20,000
Funding Body: University of Newcastle

Project Team
Conjoint Associate Professor Murray Cairns, Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Pilot GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020062006
GNo:G0186685

2005 (2 grants)

High throughput proteomics - Thermo Finnigan ProteomeX LCQ Integrated Proteomicis Workstation$207,189
Funding Body: ARC (Australian Research Council)

Schizophrenia DNA Bank$119,500
Funding Body: Australian Rotary Health

SchemeRole
ProjectInvestigator
Total AmountFunding StartFunding Finish
$119,50020052006
GNo:17794418

2004 (5 grants)

Senior research Officer Salary$246,800
Funding Body: Schizoprhenia Research Institute (formerly NISAD)

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$246,80020042007
GNo:17794489

Biacore3000-Expansion of Proteomics Facility$187,341
Funding Body: ARC (Australian Research Council)

Project Team
Professor Alistair Sim, Laureate Professor John Aitken, Emeritus Professor Peter Dunkley, Emeritus Professor John Rostas, Associate Professor Phillip Dickson, Emeritus Professor Leonie Ashman, Professor Roger Smith, Professor Gordon Burns, Professor Adam McCluskey, Associate Professor Paul Tooney, Dr Fraser Ross, Conjoint Professor Ray Rose
SchemeRole
Linkage Infrastructure Equipment & Facilities (LIEF)Investigator
Total AmountFunding StartFunding Finish
$187,34120042004
GNo:G0183030

Analysis of gene expression in psychosis using microarray technology$93,474
Funding Body: Hunter Medical Research Institute

SchemeRole
Brain and Mental Health Reseacrh program Infrastructure fundingChief Investigator
Total AmountFunding StartFunding Finish
$93,47420042006
GNo:17794450

Investigation of the contribution of the use of cannabis in the development of schizophrenia in gentically predisposed individuals$16,000
Funding Body: Hunter Medical Research Institute

Project Team
Dr Fraser Ross, Associate Professor Paul Tooney
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$16,00020042004
GNo:G0183754

Investigation of the contribution of the use of cannabis in the development of schizophrenia in genetically predisposed individuals$5,000
Funding Body: NISAD

SchemeRole
Investigator
Total AmountFunding StartFunding Finish
$5,00020042004
GNo:17794511

2003 (2 grants)

DNA Bank for Schizophrenia Research$15,000
Funding Body: The Percy Baxter Foundation

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$15,00020032003
GNo:17794571

Assessment of somatosensory function in subjects with schizophrenia: touch, pain and axon reflex flare.$11,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Conjoint Professor Vaughan Carr, Associate Professor Paul Tooney, Doctor Carmel Loughland, Professor Mike Calford
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$11,00020032003
GNo:G0182466

2002 (5 grants)

The Genetics of Schizophrenia.$60,000
Funding Body: Neuroscience Institute of Schizophrenia and Allied Disorders

Project Team
Associate Professor Paul Tooney, Professor Rodney Scott
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$60,00020022004
GNo:G0182268

The role of tachykinins and their receptors in schizophrenia: An investigation at a cellular and genetic level.$60,000
Funding Body: Neuroscience Institute of Schizophrenia and Allied Disorders

Project Team
Associate Professor Paul Tooney, Conjoint Professor Loris Chahl, Professor Rodney Scott
SchemeRole
Postgraduate Research ScholarshipChief Investigator
Total AmountFunding StartFunding Finish
$60,00020022004
GNo:G0182269

The development of microarray technology for biomedical research in the Hunter Region.$21,000
Funding Body: Hunter Medical Research Institute

Project Team
Associate Professor Paul Tooney, Doctor Douglas Dorahy, Professor Rodney Scott
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$21,00020022004
GNo:G0181184

Equipment for the analysis of gene expression in psychosis using microarray technology$15,000
Funding Body: NISAD

SchemeRole
Chief Investigator
Total AmountFunding StartFunding Finish
$15,00020022002
GNo:17794597

The Effect of chronic treatment with a Tachykinin NK1 receptor antagonist on the stress response to opiod withdrawal in guinea-pigs$9,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$9,00020022002
GNo:G0181266

2001 (2 grants)

Tachykinin NK, receptors in guinea-pig and human limbic systems: role in the response to stress$10,000
Funding Body: University of Newcastle

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020012001
GNo:G0180106

NK1 receptor immunoreactivity is increased in the prefrontal cortex in schizophrenia$1,500
Funding Body: Ian Potter Foundation

SchemeRole
Post-Doctoral Travel GrantsChief Investigator
Total AmountFunding StartFunding Finish
$1,50020012001
GNo:17794627

2000 (2 grants)

Neurolucida Imaging System.$24,000
Funding Body: NHMRC (National Health & Medical Research Council)

Project Team
Conjoint Professor Loris Chahl, Associate Professor Paul Tooney, Emeritus Professor Peter Dunkley, Emeritus Professor John Rostas
SchemeRole
Equipment GrantInvestigator
Total AmountFunding StartFunding Finish
$24,00020002000
GNo:G0179167

The effects of anti-psychotic drugs on the distribution of tachykinin receptors in Guinea Pig brain.$4,500
Funding Body: University of Newcastle

Project Team
Associate Professor Paul Tooney
SchemeRole
Early Career Researcher GrantChief Investigator
Total AmountFunding StartFunding Finish
$4,50020002000
GNo:G0179335
Edit

Research Supervision

Number of current supervisions1
Total current UoN PhD EFTSL0.5

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20142018PhD(Experimental Pharmacology)Principal SupervisorNeurobiological Investigation of Interstitial White Matter Neurons in a Maternal Infection Activation Model of Schizophrenia

Past Supervision

YearProgramSupervisor TypeResearch Title
2013PhD(Experimental Pharmacology)Principal SupervisorFunctional Analysis of Gene and microRNA Expression Profiling in Schizophrenia: Brain, Blood and Antipsychotics
2013PhD(Experimental Pharmacology)Co-SupervisorPost-Transcriptional Gene Regulation in Schizophrenia, Antipsychotic Drug Treatment and the Developing Brain
2013PhD (Behavioural Science)Co-SupervisorMicroarray Gene Expression and Cerebral Cortical Grey Matter Changes in Treatment Naive Schizophrenia Patients in Sri Lanka
2013PhD(Experimental Pharmacology)Co-SupervisorGenomic Characterisation of Small RNA-Mediated Post-Transcriptional Gene Regulation
2011PhD(Experimental Pharmacology)Co-SupervisorPost-transcriptional Gene Silencing in Neuronal Differentiation, Development and Schizophrenia
2010PhD (Anatomy)Co-SupervisorCannabinoid Signaling Mechanisms in the Central Nervous System
2006PhD (Medical Biochemistry)Principal SupervisorInvestigation of Cellular and Molecular Changes in the Amygdala in Schizophrenia
2006PhD (Medical Genetics)Co-SupervisorGene Expression Profiling in Schizophrenia
Edit

Associate Professor Paul Tooney

Work Phone(02) 4921 8691
Fax(02) 492 17903
Email
PositionAssociate Professor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaPharmacy and Experimental Pharmacology
Office
MS614,
Medical Sciences,
Callaghan
University Drive
Callaghan NSW 2308
Australia
URL:www.newcastle.edu.au/profile/paul-tooney